David Béchard
Fundador en Cytune Pharma SAS .
Perfil
David Béchard is the founder.
He founded Endotis Pharma SARL in 2003, where he served as President & Chief Executive Officer from 2003 to 2012.
He also founded Cytune Pharma SAS in 2007 and currently holds the title of Chairman.
Dr. Béchard's former job includes being Vice President at Atlanpole Biotherapy.
In terms of education, Dr. Béchard is a graduate of École des Hautes Études Commerciales de Paris.
Cargos activos de David Béchard
| Empresas | Cargo | Inicio |
|---|---|---|
Cytune Pharma SAS
 Cytune Pharma SAS Miscellaneous Commercial ServicesCommercial Services Cytune Pharma SAS develops and manufactures immunotherapeutic agents for the treatment of cancer. It offers CYP 0150 produced by recombinant technology adapted to pharmaceutical processes and is the result of a single translation. The company was founded by David Béchard and Yannick Jacques on November 15, 2007 and is headquartered in Nantes, France. | Fundador | 15/11/2007 |
Antiguos cargos conocidos de David Béchard.
| Empresas | Cargo | Fin |
|---|---|---|
| Atlanpole Biotherapy | Corporate Officer/Principal | - |
Endotis Pharma SARL
 Endotis Pharma SARL Pharmaceuticals: MajorHealth Technology Endotis Pharma SARL is a holding company, which is engaged in the development of differentiated cardiovascular therapeutics based on validated targets and modes of action. The company was founded in 2003 and it is headquartered in Romainville, France. | Fundador | - |
Formación de David Béchard.
| École des Hautes Études Commerciales de Paris | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
Endotis Pharma SARL
Endotis Pharma SARL Pharmaceuticals: MajorHealth Technology Endotis Pharma SARL is a holding company, which is engaged in the development of differentiated cardiovascular therapeutics based on validated targets and modes of action. The company was founded in 2003 and it is headquartered in Romainville, France. | Health Technology |
Cytune Pharma SAS
Cytune Pharma SAS Miscellaneous Commercial ServicesCommercial Services Cytune Pharma SAS develops and manufactures immunotherapeutic agents for the treatment of cancer. It offers CYP 0150 produced by recombinant technology adapted to pharmaceutical processes and is the result of a single translation. The company was founded by David Béchard and Yannick Jacques on November 15, 2007 and is headquartered in Nantes, France. | Commercial Services |
| Atlanpole Biotherapy |
- Bolsa de valores
- Insiders
- David Béchard
